Medications with Generic Name Beginning ‘C’

Page 1 of 498 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Ruconest (C1 Esterase Inhibitor Recombinant)

RUCONEST is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). Limitation of Use:…

Bioconnection B.V.21 October 2019

Ruconest (C1 Esterase Inhibitor Recombinant)

RUCONEST is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). Limitation of Use:…

Pharming Healthcare Inc.30 April 2020

Ruconest (C1 Esterase Inhibitor Recombinant)

RUCONEST is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).Limitation of Use:…

Tjoapack Netherlands BV24 October 2022

Jevtana (Cabazitaxel)

JEVTANA is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing…

Sanofi-Aventis U.S. LLC25 February 2021

Cabergoline

Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. CONTRAINDICATIONS: Cabergoline Tablets USP are…

Ingenus Pharmaceuticals, LLC19 October 2019

Page 1 of 498 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.